Pharmaceutical

Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

MedicaloidNovember 27, 2020

November 27, 2020

The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen...

Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

MedicaloidNovember 26, 2020

November 26, 2020

New Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here on Thursday with Dr M V...

Covid-19: Prime Minister Modi to visit Serum Institute of India in Pune on November 28

MedicaloidNovember 26, 2020November 26, 2020

November 26, 2020November 26, 2020

PUNE: Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the...

Gandhi medical college, peoples university to be part of Covaxin trial

MedicaloidNovember 26, 2020November 26, 2020

November 26, 2020November 26, 2020

BHOPAL: Two medical colleges in Bhopal, Gandhi Medical College (GMC) and Peoples University are to be part of Phase 3 trials of Covaxin— India’s indigenous...

Laurus Labs enters biotechnology segment by acquiring a majority stake in Richcore Lifesciences Hyderabad

MedicaloidNovember 26, 2020

November 26, 2020

(Representative image) November 25, 2020, Laurus Labs has signed a definitive agreement to acquire a majority stake in Richcore Lifesciences Pvt Ltd (Richcore). Richcore, a...

Pune: Vaccine supply plan to be ready in two weeks

MedicaloidNovember 26, 2020

November 26, 2020

Pune: Members of the state vaccine task force said they were set to ready a distribution plan for frontline workers and other at-risk groups. The...

IIL to set up viral antigen unit, to cater to Covid-19 vaccine

MedicaloidNovember 26, 2020November 26, 2020

November 26, 2020November 26, 2020

Hyderabad: Vaccine maker Indian Immunologicals Ltd (IIL), which is developing a Covid-19 vaccine candidate along with Griffith University of Australia, is setting up a new...

Covid-19: National vaccine administration policy in the works to get jab job done

MedicaloidNovember 26, 2020

November 26, 2020

New Delhi: The Centre is finalising a national vaccine administration policy to streamline inoculation of the entire population against Covid-19. The vaccination programme is expected...

Delhi: 74 hospitals linked to 19 Covid funeral sites

MedicaloidNovember 26, 2020

November 26, 2020

Delhi’s only Covid-designated crematorium at Punjabi Bagh will now be reopened for non-Covid cremations as well. New Delhi: With the capital recording over 100 Covid...

Covaxx inks supply deals worth $2.8B in lead-up to coronavirus vaccine midstage trials

MedicaloidNovember 25, 2020

November 25, 2020

While some of the leading players in the race for a COVID-19 vaccine are racing toward the finish line, a range of smaller challengers is still...

Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

Covid-19: Prime Minister Modi to visit Serum Institute of India in Pune on November 28

Gandhi medical college, peoples university to be part of Covaxin trial

Laurus Labs enters biotechnology segment by acquiring a majority stake in Richcore Lifesciences Hyderabad

Pune: Vaccine supply plan to be ready in two weeks

IIL to set up viral antigen unit, to cater to Covid-19 vaccine

Covid-19: National vaccine administration policy in the works to get jab job done

Delhi: 74 hospitals linked to 19 Covid funeral sites

Covaxx inks supply deals worth $2.8B in lead-up to coronavirus vaccine midstage trials

3 Basic Moves for a Whole-body Kettlebell Workout...

Listen: Plasma and Immunity

To Build Emotional Strength, Expand Your Brain

Bengaluru: Aam Aadmi party clinic offers free treatment

Keto Egg Wrap with Collard Greens Recipe, 3...

AstraZeneca signs MoU with RSSDI for diabetes awareness

View: Is India ready for Covid vaccine? Here’s what the country should do

‘Reason to believe effective vaccine for general public in India to be available by Apr 2021’

AstraZeneca likely to run additional global vaccine test, CEO Pascal Soriot says

astrazeneca: Questions over AstraZeneca’s COVID-19 vaccine data risk delaying approval

How to Enjoy Your Holiday Feast, Guilt-Free

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

COVID pandemic underlined importance of integrated healthcare system: Jitendra Singh

AstraZeneca faces more vaccine questions after manufacturing error

AstraZeneca inks pact with Research Society for Study of Diabetes in India